{"id":"https://openalex.org/W2043900831","doi":"https://doi.org/10.1210/jc.2010-2081","title":"DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes","display_name":"DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes","alternate_titles":[],"publication_year":2011,"publication_date":"2011-02-09","ids":{"openalex":"https://openalex.org/W2043900831","doi":"https://doi.org/10.1210/jc.2010-2081","mag":"2043900831","pmid":"https://pubmed.ncbi.nlm.nih.gov/21307137"},"language":"en","primary_location":{"id":"doi:10.1210/jc.2010-2081","doi":"https://doi.org/10.1210/jc.2010-2081","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2010-2081","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2043900831"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004471830","display_name":"Thomas Blevins","orcid":"https://orcid.org/0000-0003-3746-9606","observed_orcids":["https://orcid.org/0000-0003-3746-9606"]},"institutions":[{"id":"https://openalex.org/I4210135305","display_name":"Texas Diabetes & Endocrinology","ror":"https://ror.org/034cxfp17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210135305"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas Blevins","raw_affiliation_strings":["Texas Diabetes and Endocrinology, 6500 North Mopac Expressway, Building 3, Suite 200, Austin, Texas 78731, USA. tblevins@texasdiabetes.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Diabetes and Endocrinology, 6500 North Mopac Expressway, Building 3, Suite 200, Austin, Texas 78731, USA. tblevins@texasdiabetes.com","institution_ids":["https://openalex.org/I4210135305"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111673292","display_name":"John R. Pullman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Pullman","raw_affiliation_strings":["Mercury St. Medical, Clinical Research Department, (J.P.), Butte, Montana 59701"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mercury St. Medical, Clinical Research Department, (J.P.), Butte, Montana 59701","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004842224","display_name":"Jaret L. Malloy","orcid":"https://orcid.org/0000-0001-6937-9854","observed_orcids":["https://orcid.org/0000-0001-6937-9854"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaret Malloy","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., Medical Development (J.M., K.T., C.S., L.P.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., Medical Development (J.M., K.T., C.S., L.P.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101819344","display_name":"Ping Yan","orcid":"https://orcid.org/0000-0003-4237-9875","observed_orcids":["https://orcid.org/0000-0003-4237-9875"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ping Yan","raw_affiliation_strings":["Corporate Analytics (P.Y.), San Diego, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corporate Analytics (P.Y.), San Diego, California 92121","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110734241","display_name":"Kristin Taylor","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristin Taylor","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., Medical Development (J.M., K.T., C.S., L.P.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., Medical Development (J.M., K.T., C.S., L.P.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059677593","display_name":"Christine T. Schulteis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine Schulteis","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., Medical Development (J.M., K.T., C.S., L.P.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., Medical Development (J.M., K.T., C.S., L.P.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062021087","display_name":"MICHAEL E. TRAUTMANN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Trautmann","raw_affiliation_strings":["Eli Lilly & Co., Lilly Diabetes, (M.T.), Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly & Co., Lilly Diabetes, (M.T.), Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":null,"display_name":"Lisa Porter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa Porter","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., Medical Development (J.M., K.T., C.S., L.P.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., Medical Development (J.M., K.T., C.S., L.P.)","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004471830"],"corresponding_institution_ids":["https://openalex.org/I4210135305"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":38.0265,"has_fulltext":false,"cited_by_count":465,"citation_normalized_percentile":{"value":0.99903079,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"96","issue":"5","first_page":"1301","last_page":"1310"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9210000038146973},{"id":"https://openalex.org/keywords/once-weekly-dosing","display_name":"weekly dosing","score":0.8190000057220459},{"id":"https://openalex.org/keywords/twice-daily-dosing","display_name":"twice-daily dosing","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9120000004768372},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":1.0},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9610000252723694},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9399999976158142},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.8199999928474426},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.9210000038146973},{"id":"https://openalex.org/keywords/injection-site-reactions","display_name":"injection site reactions","score":0.9430000185966492},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.890999972820282},{"id":"https://openalex.org/keywords/drug-naive-patients","display_name":"drug-naive patients","score":0.7039999961853027}],"concepts":[{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.9706382751464844},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8387997150421143},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.823442280292511},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7533848285675049},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6307915449142456},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5646982192993164},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5484580993652344},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5144791603088379},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.5097166895866394},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.4727034568786621},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.463817298412323},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4555983245372772},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.43010950088500977},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3720053434371948},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.21596050262451172},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077270","descriptor_name":"Exenatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000178","qualifier_name":"diet therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005081","descriptor_name":"Exercise Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014688","descriptor_name":"Venoms","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1210/jc.2010-2081","doi":"https://doi.org/10.1210/jc.2010-2081","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2010-2081","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:21307137","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21307137","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1970065450","https://openalex.org/W1984740259","https://openalex.org/W1986085856","https://openalex.org/W1994636940","https://openalex.org/W2004409542","https://openalex.org/W2004977380","https://openalex.org/W2013851956","https://openalex.org/W2017044017","https://openalex.org/W2028272916","https://openalex.org/W2065319712","https://openalex.org/W2070710390","https://openalex.org/W2071835038","https://openalex.org/W2073996229","https://openalex.org/W2084534846","https://openalex.org/W2101613382","https://openalex.org/W2101718966","https://openalex.org/W2107949845","https://openalex.org/W2108646121","https://openalex.org/W2115012618","https://openalex.org/W2121894019","https://openalex.org/W2136254957","https://openalex.org/W2137352234","https://openalex.org/W2138077952","https://openalex.org/W2138290933","https://openalex.org/W2139485303","https://openalex.org/W2142400535","https://openalex.org/W2146901298","https://openalex.org/W2159198773","https://openalex.org/W2160001758","https://openalex.org/W2162934281","https://openalex.org/W2164416879","https://openalex.org/W2169274492","https://openalex.org/W2170606300","https://openalex.org/W2172221709","https://openalex.org/W2337454357","https://openalex.org/W2344620176","https://openalex.org/W2596624061"],"related_works":["https://openalex.org/W2152141170","https://openalex.org/W2138077952","https://openalex.org/W1975612744","https://openalex.org/W7097067969","https://openalex.org/W2129934471","https://openalex.org/W1989713397","https://openalex.org/W2010976066","https://openalex.org/W2041728881","https://openalex.org/W2114839813","https://openalex.org/W3092463639"],"abstract_inverted_index":{"CONTEXT:":[0],"We":[1],"wanted":[2],"to":[3,30,155,214,241],"understand":[4],"the":[5,27,68,244],"effects":[6,32],"of":[7,17,26,33],"once-weekly":[8],"vs.":[9,176,183,198],"twice-daily":[10],"glucagon-like":[11,274],"peptide-1":[12,275],"receptor":[13,276],"agonism":[14,277],"for":[15,128,135,143],"treatment":[16],"patients":[18,78,292],"with":[19,79,113,252,256,266,278,285,289,293],"type":[20,80,294],"2":[21,81,126,295],"diabetes.":[22,296],"OBJECTIVE:":[23],"The":[24,60,72,149],"objective":[25],"study":[28,61,73],"was":[29,52,62,75,158,249],"compare":[31],"exenatide":[34,39],"once":[35],"weekly":[36],"(ExQW)":[37],"and":[38,48,190,226,238],"twice":[40],"daily":[41],"(ExBID)":[42],"on":[43],"glycemic":[44,283],"control,":[45,284],"body":[46,210],"weight,":[47],"safety.":[49],"DESIGN:":[50],"This":[51],"a":[53],"24-wk,":[54],"randomized,":[55],"open-label,":[56],"comparator-controlled":[57],"study.":[58],"SETTING:":[59],"conducted":[63],"at":[64],"43":[65],"sites":[66],"in":[67,151,178,208,219,281,291],"United":[69],"States.":[70],"PATIENTS:":[71],"population":[74],"252":[76],"intent-to-treat":[77],"diabetes":[82],"[baseline":[83],"(mean":[84],"\u00b1":[85,91,97,102,174,181,185,195,200,223,228],"SD):":[86],"glycosylated":[87],"hemoglobin":[88],"(HbA1c)":[89],"8.4":[90],"1.2%,":[92],"fasting":[93,191],"plasma":[94,192],"glucose":[95,193],"171":[96],"47":[98],"mg/dl,":[99],"weight":[100,211],"96":[101],"20":[103,144],"kg]":[104],"that":[105],"were":[106,217,233,261],"drug":[107],"na\u00efve":[108],"(19%)":[109],"or":[110,116,131],"previously":[111],"treated":[112],"one":[114],"(47%)":[115],"multiple":[117],"(35%)":[118],"oral":[119],"antidiabetic":[120],"medications.":[121],"INTERVENTIONS:":[122],"Interventions":[123],"included":[124],"ExQW":[125,164,253,279],"mg":[127],"24":[129,157,162,216],"wk":[130,137,156,215],"ExBID":[132,140,177,257,290],"5":[133,196,201],"\u03bcg":[134,142],"4":[136],"followed":[138],"by":[139],"10":[141],"wk.":[145],"MAIN":[146],"OUTCOME":[147],"MEASURE:":[148],"change":[150],"HbA1c":[152,179],"from":[153,169,212],"baseline":[154,170,213],"measured.":[159],"RESULTS:":[160],"At":[161],"wk,":[163],"produced":[165],"significantly":[166],"greater":[167],"changes":[168],"(least":[171],"squares":[172],"mean":[173,209],"SE)":[175],"(-1.6":[180],"0.1%":[182],"-0.9":[184],"0.1%;":[186],"P":[187,203],"<":[188],"0.0001)":[189],"(-35":[194],"mg/dl":[197],"-12":[199],"mg/dl;":[202],"=":[204],"0.0008).":[205],"Similar":[206],"reductions":[207],"observed":[218],"both":[220],"groups":[221,298],"(-2.3":[222],"0.4":[224,229],"kg":[225],"-1.4":[227],"kg).":[230],"Both":[231,297],"treatments":[232],"generally":[234],"well":[235],"tolerated.":[236],"Transient":[237],"predominantly":[239],"mild":[240],"moderate":[242],"nausea,":[243,287],"most":[245],"frequent":[246],"adverse":[247],"event,":[248],"less":[250,286],"common":[251,265],"(14%)":[254],"than":[255],"(35%).":[258],"Injection-site":[259],"reactions":[260],"infrequent,":[262],"but":[263],"more":[264],"ExQW.":[267],"No":[268],"major":[269],"hypoglycemia":[270],"occurred.":[271],"CONCLUSIONS:":[272],"Continuous":[273],"resulted":[280],"superior":[282],"compared":[288],"lost":[299],"weight.":[300]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2043900831","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":17},{"year":2018,"cited_by_count":30},{"year":2017,"cited_by_count":36},{"year":2016,"cited_by_count":37},{"year":2015,"cited_by_count":43},{"year":2014,"cited_by_count":55},{"year":2013,"cited_by_count":54},{"year":2012,"cited_by_count":61}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
